We are a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., the world’s largest manufacturer of transdermal patches. We serve as Hisamitsu's growth platform in U.S. prescription pharmaceuticals. Hisamitsu develops and markets both prescription and over-the-counter ("OTC") pharmaceutical products. Its leading prescription products in Japan are the Mohrus® patch and Mohrus-Tape® ketoprofen pain relief products. Available in nearly 50 countries including the U.S., Hisamitsu's leading OTC products are sold under the Salonpas® brand for pain relief. Hisamitsu was founded in 1847 and is principally located in Saga, Japan.
Noven and Hisamitsu share a common vision of benefiting patients, and to this end work closely and collaboratively across a range of functions including product development, manufacturing, and business development.
For additional information on Hisamitsu, click here.
For additional information on Hisamitsu's Salonpas® brand of products click here.
Specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products.
Year of Incorporation:
President & Chief Executive Officer:
Jeffrey F. Eisenberg
Media, General Business
& Other Inquiries:
Joseph C. Jones
Vice President – Corporate Affairs
Partnering and Other Business Development Opportunities
Community Support:Corporate Social Responsibility
Noven is a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc.
Noven Therapeutics, LLC is Noven's specialty pharmaceuticals marketing and sales company consisting of two specialty field sales forces focusing on Women's Health and Central Nervous System products.